BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28594869)

  • 1. Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction.
    Nafisinia M; Riley LG; Gold WA; Bhattacharya K; Broderick CR; Thorburn DR; Simons C; Christodoulou J
    PLoS One; 2017; 12(6):e0178125. PubMed ID: 28594869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound heterozygous mutations in glycyl-tRNA synthetase are a proposed cause of systemic mitochondrial disease.
    McMillan HJ; Schwartzentruber J; Smith A; Lee S; Chakraborty P; Bulman DE; Beaulieu CL; Majewski J; Boycott KM; Geraghty MT
    BMC Med Genet; 2014 Mar; 15():36. PubMed ID: 24669931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
    Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
    J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.
    Sivakumar K; Kyriakides T; Puls I; Nicholson GA; Funalot B; Antonellis A; Sambuughin N; Christodoulou K; Beggs JL; Zamba-Papanicolaou E; Ionasescu V; Dalakas MC; Green ED; Fischbeck KH; Goldfarb LG
    Brain; 2005 Oct; 128(Pt 10):2304-14. PubMed ID: 16014653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
    Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
    Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V.
    Dubourg O; Azzedine H; Yaou RB; Pouget J; Barois A; Meininger V; Bouteiller D; Ruberg M; Brice A; LeGuern E
    Neurology; 2006 Jun; 66(11):1721-6. PubMed ID: 16769947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation of the glycyl-tRNA synthetase (GARS) gene associated with Charcot-Marie-Tooth type 2D in a Chinese family.
    Sun A; Liu X; Zheng M; Sun Q; Huang Y; Fan D
    Neurol Res; 2015 Sep; 37(9):782-7. PubMed ID: 26000875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].
    Kawakami N; Komatsu K; Yamashita H; Uemura K; Oka N; Takashima H; Takahashi R
    Rinsho Shinkeigaku; 2014; 54(11):911-5. PubMed ID: 25420567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
    Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
    Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation.
    Oprescu SN; Chepa-Lotrea X; Takase R; Golas G; Markello TC; Adams DR; Toro C; Gropman AL; Hou YM; Malicdan MCV; Gahl WA; Tifft CJ; Antonellis A
    Hum Mutat; 2017 Oct; 38(10):1412-1420. PubMed ID: 28675565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy.
    Abe A; Hayasaka K
    J Hum Genet; 2009 May; 54(5):310-2. PubMed ID: 19329989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V.
    Lee HJ; Park J; Nakhro K; Park JM; Hur YM; Choi BO; Chung KW
    J Peripher Nerv Syst; 2012 Dec; 17(4):418-21. PubMed ID: 23279345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.
    Banks GT; Bros-Facer V; Williams HP; Chia R; Achilli F; Bryson JB; Greensmith L; Fisher EM
    PLoS One; 2009 Jul; 4(7):e6218. PubMed ID: 19593442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
    Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
    PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Features in a Series of Eight Unrelated Patients with Neuropathy Due to Glycyl-tRNA Synthetase (GARS) Variants.
    Forrester N; Rattihalli R; Horvath R; Maggi L; Manzur A; Fuller G; Gutowski N; Rankin J; Dick D; Buxton C; Greenslade M; Majumdar A
    J Neuromuscul Dis; 2020; 7(2):137-143. PubMed ID: 31985473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease.
    Yalcouyé A; Diallo SH; Coulibaly T; Cissé L; Diallo S; Samassékou O; Diarra S; Coulibaly D; Keita M; Guinto CO; Fischbeck K; Landouré G;
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00782. PubMed ID: 31173493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
    Malissovas N; Griffin LB; Antonellis A; Beis D
    Hum Mol Genet; 2016 Apr; 25(8):1528-42. PubMed ID: 27008886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
    Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
    Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS.
    Eskuri JM; Stanley CM; Moore SA; Mathews KD
    J Peripher Nerv Syst; 2012 Mar; 17(1):132-4. PubMed ID: 22462675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Novel De Novo GARS Mutations Cause Early-Onset Axonal Charcot-Marie-Tooth Disease.
    Liao YC; Liu YT; Tsai PC; Chang CC; Huang YH; Soong BW; Lee YC
    PLoS One; 2015; 10(8):e0133423. PubMed ID: 26244500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.